Novalis LifeSciences
Overview
Novalis LifeSciences is a boutique investment and advisory firm for the Life Science industry that was founded in 2017 by Marijn E. Dekkers. With a team of experienced operating executives from the Li…
Investment Focus
- Innovative life science technologies
- Strong management teams
- Scalable business models
- Potential for significant market impact
- Alignment with Novalis LifeSciences' investment focus areas
Portfolio Companies
Reach Novalis LifeSciences directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Novalis LifeSciences
What sectors does Novalis LifeSciences invest in?
Novalis LifeSciences invests in Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Synthetic Biology, and is based in United States. Novalis LifeSciences is listed as a venture capital in the ConnectSafely investor database.
What stage does Novalis LifeSciences invest at?
Novalis LifeSciences backs companies at Series A and Series B, writing cheques of 1M - 10M.
Which regions does Novalis LifeSciences invest in?
Novalis LifeSciences invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Novalis LifeSciences invested in?
Novalis LifeSciences's portfolio includes Ginkgo Bioworks, Cerevel Therapeutics, Biotalys, Mercy BioAnalytics, Sherlock Biosciences, Quanterix, Decipher Biosciences and Celsee.
How do I contact Novalis LifeSciences?
Novalis LifeSciences's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
